US and UK 'lead push against global patent pool for Covid-19 drugs' | World news | The Guardian: “In general, it is a disappointment, appalling really. There was better text that was rejected,” said Jamie Love, the director of the NGO Knowledge Ecology International. “The US, UK, Swiss and some others pushed against the WHO taking the lead in pushing for open licensing of patents and know-how for drugs and vaccines.
“In a global crisis like this, that has such a massive impact on everyone, you would expect the WHO governing body to have the backbone to say no monopolies in this pandemic. It’s one thing for a country to use its economic clout to buy preferential access to drugs or vaccines. It’s another to prevent others from manufacturing and expanding global supply.”
“In a global crisis like this, that has such a massive impact on everyone, you would expect the WHO governing body to have the backbone to say no monopolies in this pandemic. It’s one thing for a country to use its economic clout to buy preferential access to drugs or vaccines. It’s another to prevent others from manufacturing and expanding global supply.”